Erik L. Ridley and Philip Ward[email protected]Artificial IntelligenceRadNet broadens AI focus with acquisitions of Aidence, QuantibU.S. imaging services provider RadNet has acquired Dutch artificial intelligence (AI) software developers Aidence and Quantib in deals that the company hopes will enable wide-scale screening programs for lung and prostate cancer.January 23, 2022Page 1 of 1Top StoriesCTBelgian study shows AI's promise in coronary ischemiaA deep-learning model for assessing vessel-specific coronary ischemia performed well compared to invasive fractional flow reserve in a multicenter study published by European Radiology on 11 October.Artificial IntelligenceAI on the Aegean: EuSoMII congress comes to CreteDigital X-RayAI fracture detection tools tested head-to-headMolecular ImagingPSMA-PET/CT may replace NaF-PET/CT in advanced prostate cancerWomens ImagingWhat's the link between assisted reproduction and breast cancer?